ATE370243T1 - Screeningverfahren für einen auf die zellwand wirkenden arzneistoff - Google Patents

Screeningverfahren für einen auf die zellwand wirkenden arzneistoff

Info

Publication number
ATE370243T1
ATE370243T1 AT02775378T AT02775378T ATE370243T1 AT E370243 T1 ATE370243 T1 AT E370243T1 AT 02775378 T AT02775378 T AT 02775378T AT 02775378 T AT02775378 T AT 02775378T AT E370243 T1 ATE370243 T1 AT E370243T1
Authority
AT
Austria
Prior art keywords
cell wall
reporter protein
targeting site
medicinal
affecting
Prior art date
Application number
AT02775378T
Other languages
English (en)
Inventor
Akihiro Kitamura
Ryohei Nakajima
Original Assignee
Dalichi Sankyo Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalichi Sankyo Company Ltd filed Critical Dalichi Sankyo Company Ltd
Application granted granted Critical
Publication of ATE370243T1 publication Critical patent/ATE370243T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02775378T 2001-10-22 2002-10-22 Screeningverfahren für einen auf die zellwand wirkenden arzneistoff ATE370243T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001323293 2001-10-22

Publications (1)

Publication Number Publication Date
ATE370243T1 true ATE370243T1 (de) 2007-09-15

Family

ID=19140207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02775378T ATE370243T1 (de) 2001-10-22 2002-10-22 Screeningverfahren für einen auf die zellwand wirkenden arzneistoff

Country Status (9)

Country Link
US (1) US7459268B2 (de)
EP (1) EP1445327B1 (de)
JP (1) JP4204471B2 (de)
AT (1) ATE370243T1 (de)
CA (1) CA2464396A1 (de)
DE (1) DE60221883T2 (de)
ES (1) ES2294172T3 (de)
NO (1) NO20042089L (de)
WO (1) WO2003035898A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE370243T1 (de) 2001-10-22 2007-09-15 Dalichi Sankyo Company Ltd Screeningverfahren für einen auf die zellwand wirkenden arzneistoff
EP1926745A1 (de) * 2005-09-22 2008-06-04 Suntory Limited Genkodierendes zellwand-manoprotein und verwendungen davon
TWI428091B (zh) * 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
US11643438B2 (en) 2018-07-20 2023-05-09 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
CN115094142B (zh) * 2022-07-19 2024-05-28 中国医学科学院肿瘤医院 用于诊断肺肠型腺癌的甲基化标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU95105899A (ru) 1992-07-08 1997-03-20 Унилевер Н.В. (NL) Способ иммобилизации фермента, полинуклеотид, вектор, химерный блок, низшие эукариоты, способ осуществления ферментативного процесса
JPH0956384A (ja) 1995-08-25 1997-03-04 Toray Ind Inc 細胞の標識方法
EP0916726A1 (de) 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
WO1999067419A1 (en) 1998-06-25 1999-12-29 The Collaborative Group, Ltd. β(1,6)-GLUCAN SYNTHESIS AND CELL WALL ASSEMBLY ASSAY
JP2000102387A (ja) 1998-09-29 2000-04-11 Daicel Chem Ind Ltd 発光蛋白質発現組換えベクター、及びこの組換えベクターにより形質転換された酵母
AU2001252604A1 (en) * 2000-05-01 2001-11-12 Daiichi Pharmaceutical Co., Ltd. Method of screening drug acting on cell wall
ATE370243T1 (de) 2001-10-22 2007-09-15 Dalichi Sankyo Company Ltd Screeningverfahren für einen auf die zellwand wirkenden arzneistoff

Also Published As

Publication number Publication date
JP4204471B2 (ja) 2009-01-07
WO2003035898A1 (fr) 2003-05-01
ES2294172T3 (es) 2008-04-01
EP1445327B1 (de) 2007-08-15
US20050069965A1 (en) 2005-03-31
CA2464396A1 (en) 2003-05-01
JPWO2003035898A1 (ja) 2005-02-10
EP1445327A4 (de) 2005-09-14
DE60221883T2 (de) 2008-04-30
DE60221883D1 (de) 2007-09-27
EP1445327A1 (de) 2004-08-11
US7459268B2 (en) 2008-12-02
NO20042089L (no) 2004-05-21

Similar Documents

Publication Publication Date Title
YU101202A (sh) Rana dijagnoza konformacionih bolesti
BR0208597A (pt) Meio de detecção de staphylococcus aureus e/ou estafilococos com coagulose positiva e método de identificação de bactéria (s) da espécie staphylococcus aureus em uma amostra
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
EP1705645A3 (de) Vorrichtung und Verfahren zur Analyse von Sprachmodelländerungen
DE60142048D1 (de) Universelles sammelmedium
BR0116329A (pt) Aparelho e método para análise e aperfeiçoamento de produtos agrìcolas
DE60232323D1 (de) Verbessertes verfahren zum nachweis von atp
ATE412767T1 (de) Präbiotische effektanalyse
ATE438737T1 (de) Verfahren für den nachweis von erkrankungen
ATE295899T1 (de) Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
FR2878109B1 (fr) Procede d'evaluation de la comptabilite entre des applications et des dispositifs de traitement
ATE335852T1 (de) Happier mapping
ATE465410T1 (de) Vorrichtungen und verfahren zum nachweis von fruchtwasser in vaginalsekreten
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
ATE395684T1 (de) Verfahren zur analyse der grundfrequenz, verfahren und vorrichtung zur sprachkonversion unter dessen verwendung
ATE370243T1 (de) Screeningverfahren für einen auf die zellwand wirkenden arzneistoff
ATE503021T1 (de) Verfahren zum nachweis von endoglykosidase aktivität
WO2004015420A8 (en) Method for diagnosing multiple sclerosis
ATE508201T1 (de) Verfahren zur generierung eines gentechnisch veränderten organismus für das wirksubstanzscreening
ATE475097T1 (de) Erkennung von tumor-spezifischen genprodukten bei krebs
IL175692A0 (en) Method for diagnosing diseases based on levels of anti-glycan antibodies
NO20025217D0 (no) FremgangsmÕte for screening av legemiddel som virker pÕ cellevegg
ATE388448T1 (de) Verfahren zur analyse von t-lymphozyten über die t-lymphozytrezeptoren eines organismus
DE60314258D1 (de) Gtp cyclohydrolase ii als ziel für fungizide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties